Linda Moore | General Counsel |
Kevin Helash | CEO |
Jim Boyd | President and CFO |
Kevin Hammill | Chief Commercial Officer |
Ben Klieve | National Security |
Sameer Joshi | H.C. Wainright |
Bobby Burleson | Canaccord |
Adam Bubes | Adam Bubes |
Nathan Weinstein | Aegis Capital |
Good day, ladies and gentlemen, and welcome to the Marrone Bio Innovations Second Quarter 2020 Earnings Conference Call. Today's conference is being recorded. And at this time, I'd like to turn the conference over to Linda Moore, General Counsel.
Good afternoon, everyone, and thank you for joining our call. Welcome to the 2020 second quarter earnings conference call for Marrone Bio Innovations.